Influenza virus infection enhances tumour-specific CD8 + T-cell immunity, facilitating tumour control

Philine Steinbach,Eva Pastille,Lara Kaumanns,Alexandra Adamczyk,Kathrin Sutter,Wiebke Hansen,Ulf Dittmer,Jan Buer,Astrid M Westendorf,Torben Knuschke,Astrid M. Westendorf

DOI: https://doi.org/10.1371/journal.ppat.1011982

IF: 7.464

2024-01-27

PLoS Pathogens

Abstract:Influenza A virus (IAV) can cause severe respiratory infection leading to significant global morbidity and mortality through seasonal epidemics. Likewise, the constantly increasing number of cancer diseases is a growing problem. Nevertheless, the understanding of the mutual interactions of the immune responses between cancer and infection is still very vague. Therefore, it is important to understand the immunological cross talk between cancer and IAV infection. In several preclinical mouse models of cancer, including melanoma and colorectal cancer, we observed that IAV infection in the lung significantly decreased the tumour burden. Concomitantly, tumour-specific CD8 + T-cells are strongly activated upon infection, both in the tumour tissue and in the lung. CD8 + T-cell depletion during infection reverses the reduced tumour growth. Interestingly, IAV infection orchestrated the migration of tumour-specific CD8 + T-cells from the tumour into the infected lung. Blocking the migration of CD8 + T-cells prevented the anti-tumoural effect. Thus, our findings show that viral respiratory infection has significant impact on the anti-tumour CD8 + T-cell response, which will significantly improve our understanding of the immunological cross talk between cancer and infection. The Influenza A virus (IAV) causes severe respiratory infections during seasonal outbreaks, while the rising incidence of cancer presents a growing health concern, yet our understanding of the interactions between immune responses to infection and cancer is still unclear. Therefore, we aimed to decipher the immunological cross talk between cancer and IAV infection. Using preclinical mouse models of melanoma and colorectal cancer, we made intriguing observations. IAV infection in the lung led to a significant reduction in tumour growth. Additionally, the infection activated tumour-specific CD8 + T-cells, crucial components of the immune system's cancer-fighting ability, both in the lung and tumour tissue. Remarkably, when CD8 + T-cells were depleted during infection, the tumour growth reduction was reversed. It appears that IAV infection orchestrates the migration of tumour-specific CD8 + T cells from the tumour into the infected lung, since blocking migration abolished the antitumor effect. These findings shed light on the significant impact of viral respiratory infection on the anti-tumour CD8 + T-cell response, advancing our understanding of the intricate interplay between cancer and infection. Such insights hold promise for tackling these complex health challenges more effectively.

microbiology,virology,parasitology